Collectively, these results indicated that the AhRs that are constitutively activated by endogenous ITE produced in differentiated cancer cells, specifically bind to the AHRE1 of the POU5F1 promoter in vivo, thereby suppressing the transcription of Oct4. Here, POU5F1 is linked to cancer.